Carson Wealth (CWM LLC)’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXO
RCM
TCM
VP
RG
DCM
VC
AC
Carson Wealth (CWM LLC)'s ALXO Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its ALX Oncology (ALXO) stake by 32% in Q1 2026, selling an estimated $59 and leaving 65 shares worth $130. The position accounts for ﹤0.01% of the portfolio, ranked #5560.
Carson Wealth (CWM LLC) first reported a position in ALXO in Q2 2024 and has held it in 8 quarters since. The position peaked at $4K in Q1 2025. 69 funds tracked by Wall St. Rank hold ALXO as of Q1 2026.
- Carson Wealth (CWM LLC) held 65 shares of ALX Oncology worth $130 as of Q1 2026.
- Carson Wealth (CWM LLC) sold 31 ALX Oncology shares in Q1 2026, an estimated $59.
- ALX Oncology made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5560 holding.
- Carson Wealth (CWM LLC) first reported a position in ALX Oncology in Q2 2024 and has held it in 8 quarters since.
- Carson Wealth (CWM LLC)'s ALX Oncology position peaked at $4K in Q1 2025.
- 69 funds tracked by Wall St. Rank held ALX Oncology as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.